Metronomic chemotherapy following the maximum tolerated dose as a multitarget antitumor therapy affecting angiogenesis, tumor dissemination, and cancer stem cells.

Marta Vives,Mireia M. Ginestà,Kristina Gracova,Mariona Graupera,Oriol Casanovas,Gabriel Capellá,Teresa Serrano,Francesc Vinyals,Berta Laquente Sáez

Metronomic chemotherapy following the maximum tolerated dose as a multitarget antitumor therapy affecting angiogenesis, tumor dissemination, and cancer stem cells.

2017

Marta Vives
Mireia M. Ginestà
Kristina Gracova
Mariona Graupera
Oriol Casanovas
Gabriel Capellá
Teresa Serrano
Francesc Vinyals
Berta Laquente Sáez

e22057 Background: Metronomic chemotherapy has been suggested as a maintenance administration strategy after the Maximum Tolerated Dose (MTD) treatment in a multi-targeted chemo-switch schedule (C-...

Keywords:

Cancer stem cell
Angiogenesis
Internal medicine
Metronomic Chemotherapy
Maximum tolerated dose
Oncology
Pathology
Medicine
antitumor therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations